Accredited Home Lenders Holding Co. leads Monday pre-market volume
San Diego-based Accredited Home Lenders Holding Co. (Nasdaq: LEND) announced it will be acquired by Lone Star Funds for $15.10 per share, or about $400 million, in cash. The mortgage banking company said the deal is expected to be closed in the third quarter ending Sept. 30.
Telik, Inc. (Nasdaq: TELK) announced results from the third phase in a study of the biopharmaceutical company’s lung cancer drug Telcyta Assist-2. The Palo Alto, Calif.-based business said the trial missed the primary endpoint.
Biopharmaceutical company Immunomedics, Inc. (Nasdaq: IMMU) announced that treatment with the Morris Plains, N.J.-based business’ cancer drug Epratuzumab along with chemotherapy is well tolerated and feasible in children with a type of leukemia.
Cambridge, Mass.-based Ariad Pharmaceuticals, Inc. (Nasdaq: ARIA) reported patient enrollment for the third trial phase of the company’s AP23573 cancer drug will be delayed to the third quarter ending Sept. 30.
The following are the most actively traded companies in Monday pre-market trading among those with market capitalizations under $500 million:
| Price at | % | ||||||
| 9:14 et | Change | Change | Volume | Year High | Year Low |
